SCHEMBL5386741

SCHEMBL5386741

Cc1ccc(S(=O)(=O)Nc2ccc(SCc3ccc(F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
CASP6 P55212 1/20 0.49
PABPC1 P11940 1/20 0.48
METAP2 P50579 1/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPK1 P28482 1/20 0.47
GFER P55789 1/20 0.47
MCL1 Q07820 1/20 0.47
BCL2A1 Q16548 1/20 0.47
MIF P14174 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.45
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380338 0.92 POLB (0.56) POLBCASP6PABPC1METAP2ALDH1A1
Cp-778875 SCHEMBL1600965 0.92 POLB (0.58) POLBCASP6PABPC1ALDH1A1GFER
SCHEMBL5391181 0.90 POLB (0.54) POLBCASP6PABPC1ALDH1A1GFER
SCHEMBL5373887 0.90 POLB (0.49) POLBCASP6PABPC1ALDH1A1MAPK1
SCHEMBL14437715 0.90 POLB (0.56) POLBCASP6PABPC1ALDH1A1MAPK1
SCHEMBL5388054 0.90 POLB (0.56) POLBCASP6PABPC1ALDH1A1GFER
SCHEMBL5375209 0.89 POLB (0.58) POLBCASP6PABPC1ALDH1A1MAPK1
SCHEMBL5371856 0.89 POLB (0.53) POLBCASP6PABPC1ALDH1A1MAPK1
SCHEMBL5369948 0.89 POLB (0.53) POLBCASP6PABPC1ALDH1A1MAPK1
SCHEMBL5373188 0.89 POLB (0.55) POLBCASP6PABPC1ALDH1A1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
CN-1930121-A Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER PROD INC (US) 2007-03-14 CN disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885CASP6 3606/4885PABPC1 3612/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885CASP6 3811/4885PABPC1 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.